PARIS, August 28, 2011 /PRNewswire/ —
From 3D Simulated Heart Surgery and Digitized Patient Discharge
Planning, to the World’s First Sleep Apnea Mobile App for
Cardiologists – Philips gets to the Heart of Innovation
Royal Philips Electronics (NYSE: PHG, AEX: PHI) will provide
clinicians from across the globe with a glimpse of future
innovations designed to advance cardiac care, including the current
management of cardiovascular disease (CVD) and associated cardiac
conditions, during the 2011 Congress of the European Society of
Cardiology (ESC), which opens today in Paris.
Cardiovascular disease remains the main cause of death in the
European Union, claiming more than two million lives each year and
costing the economy more than €100 billion
annually.[1]
“Philips has been a consistent game-changer in the area of
health care for almost 100 years, developing innovative and
integrated patient-focused solutions, including some of the
earliest X-ray technologies,” commented Joris van den Hurk, general
manager, Cardiology Care Cycle, for Philips Healthcare. “At this
year’s ESC, we want to highlight our vision of how future
innovation will enable care-givers to transform the way
cardiovascular disease is managed at each stage – from early
detection and diagnosis, to hospital treatment and health care at
home, in order to reduce the burden of cardiac disease for
patients, doctors and society at large.”
THE FUTURE OF CARDIAC CARE
Solutions that will transform detection, diagnosis and
treatment
This vision of future innovation is exemplified by the launch of
the world’s first sleep apnea mobile application (“app”) designed
specifically for cardiologists, and aiding early detection and
diagnosis amongst their patients. It’s estimated that over 100
million people worldwide are suspected to have Obstructive Sleep
Apnea (OSA), of which more than 80 percent remain
undiagnosed.[2]
OSA is particul
‘/>”/>
